CIK 0000109657
- Non-accelerated filer
- Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 941620407
- Phone
- +1 800-304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-15 | Berk Gregory Pres. of R&D, CMO | Grant or award · Option to purchase Common Stock | +50,000 | 50,000 | ||
| 2021-02-16 | Berk Gregory Director | Grant or award | +278,058 | 278,058 | ||
| 2021-02-16 | Berk Gregory Director | Grant or award · Option to purchase Common Stock | +50,000 | 50,000 |
Page 1 of 1 · 3 trades